Total Payments
$835,202
2023 Payments
$218,000
Companies
3
Transactions
30
Medicare Patients
1,826
Medicare Billing
$280,859
Payment Breakdown by Category
Consulting$835,145 (100.0%)
Food & Beverage$56.58 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $835,145 | 27 | 100.0% |
| Food and Beverage | $56.58 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $834,800 | 26 | $0 (2023) |
| GlaxoSmithKline, LLC. | $345.00 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $56.58 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $218,000 | 14 | AstraZeneca Pharmaceuticals LP ($218,000) |
| 2022 | $308,000 | 6 | AstraZeneca Pharmaceuticals LP ($308,000) |
| 2021 | $308,800 | 6 | AstraZeneca Pharmaceuticals LP ($308,800) |
| 2019 | $56.58 | 3 | Sunovion Pharmaceuticals Inc. ($56.58) |
| 2018 | $345.00 | 1 | GlaxoSmithKline, LLC. ($345.00) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/05/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $7,400.00 | General |
| 04/05/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $57,400.00 | General |
| 04/05/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $49,400.00 | General |
| 04/05/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $43,600.00 | General |
| 04/05/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $16,800.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $8,800.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 02/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 02/08/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $16,200.00 | General |
| 02/18/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $86,000.00 | General |
| 02/18/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $61,600.00 | General |
| 02/18/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $55,600.00 | General |
| 02/18/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $55,400.00 | General |
| 02/18/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $27,000.00 | General |
| 02/18/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $22,400.00 | General |
| 10/04/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $35,400.00 | General |
| 09/03/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $177,400.00 | General |
| 03/10/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $94,600.00 | General |
| 03/10/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 03/10/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 330 | 584 | $333,342 | $47,070 |
| 2022 | 10 | 398 | 825 | $371,486 | $69,538 |
| 2021 | 13 | 548 | 1,090 | $520,750 | $89,929 |
| 2020 | 12 | 550 | 965 | $493,120 | $74,321 |
Total Patients
1,826
Total Services
3,464
Medicare Billing
$280,859
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 188 | $109,761 | $16,396 | 14.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 179 | $59,010 | $10,966 | 18.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 62 | $26,224 | $5,786 | 22.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 34 | 34 | $41,308 | $5,169 | 12.5% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 19 | 24 | $25,872 | $3,195 | 12.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $11,854 | $2,340 | 19.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $5,514 | $1,239 | 22.5% |
| 31632 | Biopsy of lobe of lung using an endoscope, each additional lobe | Facility | 2023 | 18 | 23 | $5,704 | $889.41 | 15.6% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 11 | 14 | $12,600 | $678.34 | 5.4% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 24 | 31 | $35,495 | $412.81 | 1.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 189 | $97,572 | $17,816 | 18.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 53 | 86 | $91,074 | $14,772 | 16.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 224 | $53,832 | $12,506 | 23.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 134 | $39,116 | $10,937 | 28.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 31 | $16,544 | $4,875 | 29.5% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2022 | 21 | 24 | $22,680 | $3,141 | 13.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 20 | 72 | $11,232 | $2,212 | 19.7% |
| M0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise | Office | 2022 | 13 | 15 | $2,265 | $2,188 | 96.6% |
| 31632 | Biopsy of lobe of lung using an endoscope, each additional lobe | Facility | 2022 | 19 | 22 | $5,456 | $832.12 | 15.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 25 | 28 | $31,715 | $259.79 | 0.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 222 | 363 | $225,007 | $35,596 | 15.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 39 | 186 | $54,514 | $14,319 | 26.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 51 | 227 | $49,302 | $12,829 | 26.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 44 | 72 | $76,248 | $12,322 | 16.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 30 | 32 | $17,780 | $5,042 | 28.4% |
About Dr. Derek Byers, MD
Dr. Derek Byers, MD is a Pulmonary Disease healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407074701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Byers, MD has received a total of $835,202 in payments from pharmaceutical and medical device companies, with $218,000 received in 2023. These payments were reported across 30 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($835,145).
As a Medicare-enrolled provider, Byers has provided services to 1,826 Medicare beneficiaries, totaling 3,464 services with total Medicare billing of $280,859. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Saint Louis, MO
- Active Since 04/23/2007
- Last Updated 04/15/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1407074701
Products in Payments
- ANORO (Drug) $345.00
- LONHALA MAGNAIR (Drug) $56.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Saint Louis
Joseph Ojile, M.d, M.D
Pulmonary Disease — Payments: $978,724
Pulmonary Disease $978,724
Dr. Alexander Chen, Md, MD
Pulmonary Disease — Payments: $859,735
Pulmonary Disease $859,735
Dr. Marin Kollef, Md, MD
Pulmonary Disease — Payments: $588,781
Pulmonary Disease $588,781
Dr. Praveen Chenna, Md, MD
Pulmonary Disease — Payments: $265,830
Pulmonary Disease $265,830
Dr. Murali Chakinala, Md, MD
Pulmonary Disease — Payments: $211,522
Pulmonary Disease $211,522
Dr. Janet Lee, Md, MD
Pulmonary Disease — Payments: $142,540
Pulmonary Disease $142,540